We prospectively investigated endoscopic findings of the upper digestive tract in @entity1 with @entity135 , from 1992 to 2001. Of 687 @entity1 with H _ N @entity5 were found to affect 74 @entity1 (10.8%). The 74 @entity1 consisted of 49 (66.2%) with the superficial type and 25 (33.8%) with the advanced type. Other @entity5 were detected in 32 cases (4.7%), including 21 @entity356 . The incidence was highest in @entity1 with @entity5 (32.4%), whereas the incidences in those with @entity5 and @entity5 were 14.3% and 13.1%, respectively. The incidence of @entity5 was lower than that of stage II, III, or IV @entity5 . Therapy for superficial @entity418 consisted of trisection for endoscopic mucosal resection (EMR), surgery, and no treatment. Surgery, radiation therapy, or no treatment was selected in advanced type. For double @entity5 of H _ N and esophagus, treatment should be selected in consideration of the prognosis of the disease. These findings suggest that endoscopy with the Lugol-spraying method should be performed in H _ N @entity5 for early detection of @entity418 .

[Clinical evaluation of XXXX complicated with @entity135 ].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity135 :: ('MESH:D006258', 'Disease') :: ['head and neck (H _ N) cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['mesopharyngeal cancer', 'stage I cancers', 'cancers', 'additional cancers', 'hypopharyngeal cancer', 'cancer, esophageal cancers', 'oral floor cancer'] @entity418 :: ('MESH:D004938', 'Disease') :: ['esophageal cancers'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric cancers']
@entity418 :: (MESH:D004938,Disease) :: ['esophageal cancer']
